Small breaks for small businesses
Article Abstract:
Falling interest rates in Australia are causing banks to offer financial services and loans to the substantial but overlooked small business sector. Competition for small business loans has led to a cash-rate margin reduction from 5.1% in June 1997 to 4.1% in December 1998. The average interest rate for a small business loan secured by a home is 6.95%, only 0.45% greater than a housing loan. ANZ Bank has offered two new products: the business mortgage loan with 100% offset and the business saver, at 6.5% interest.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Ostriches come home to roost
Article Abstract:
The Wallco Ostrich Corp. promised investors a low-risk, high gains ostrich breeding scheme, but the company collapsed when the price of ostrich products did. Wallco owes creditors about $13-19 million. In 1995, a pair of ostriches may have been worth at least $50,000, but in 1999, a pair might fetch $1000-10,000. In 1997, the Australian Securities and Investments Commission ordered the withdrawal of Wallco's prospectus.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
For ailing profits, Sigma prescribes a spending cure
Article Abstract:
Sigma Pharmaceuticals has manufacturing, wholesale and retail operations. The company is the second largest wholesaler in Australia with market share of 29%. Sigma plans to expand its services to increase its market share.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: 4 drug makers move to settle in pricing suit. Drug maker to close plants and cut jobs
- Abstracts: Cell Pathways is testing drug it believes can prevent and treat certain cancers. DuPont gets FDA clearance for AIDS drug
- Abstracts: Unashamedly greedy for success. Virtual monitoring gets real. Diverse tactics beat a big freeze